Iron Deficiency Anaemia
A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-04)
Seeking subjects who have been diagnosed with Iron Deficiency
Study Length: 8 weeks
Target Age/Sex: 18 years and older, Female
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.